A rise in the demand for private GP services in the UK and advancements in medical technology are driving growth in the private GP EHR market, despite concerns over data security and technical issues. Search data reveals a 156% increase in private GP searches between 2019 and 2022, while AI and wearable tech advances are fuelling EHR adoption.
Startup OMass Secures $310M to Advance Drug for Rare Endocrine Disorder
OMass’s molecule is vying to become an alternative to a Neurocrine Biosciences drug that is currently the only FDA-approved therapy for congenital adrenal hyperplasia. But
